Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Senseonics Holdings, Inc. - Common Stock (NY:SENS)

6.260 UNCHANGED
Last Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Senseonics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
28 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also... 
Via Benzinga
News headline image
Senseonics Holdings, Inc. Reports Second Quarter 2021 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap ↗
Senseonics' revolutionary Eversense glucose monitor may be redefining diabetes treatment, but its current contribution doesn't justify SENS stock rich valuation. 
Via InvestorPlace
News headline image
Senseonics Is a Solid Recovery Play Poised to Unlock its Potential ↗
SENS stock has rewarded patient investors well. However, this is only the beginning for the company as Eversense remains a gamechanger. 
Via InvestorPlace
News headline image
Earnings Scheduled For August 9, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
News headline image
Senseonics Holdings, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021, at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Analyzing Senseonics Holdings's Unusual Options Activity ↗
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $2.98. Sentiment:... 
Via Benzinga
News headline image
Senseonics Stock Might Actually Be Held Back By Its Meme Status ↗
Senseonics may be worth the wait, but SENS stock is largely in the hands of retail investors who are looking to profit from a short squeeze. 
Via InvestorPlace
News headline image
Analyzing Senseonics Holdings's Unusual Options Activity ↗
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $3.02. Sentiment: BEARISH... 
Via Benzinga
News headline image
Better Meme Stock: Clover Health or Senseonics Holdings? ↗
Both could be risky propositions at current valuations. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Senseonics Holdings ↗
On Friday, shares of Senseonics Holdings (AMEX:SENS) saw unusual options activity. After the option alert, the stock price moved up to $3.06. Sentiment: BEARISH Option Type:... 
Via Benzinga
News headline image
Why Senseonics Skyrocketed 340% in the First Half of 2021 ↗
The maker of continuous glucose-monitoring systems had several positive developments. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Senseonics Holdings ↗
Senseonics Holdings (AMEX:SENS) shares experienced unusual options activity on Thursday. The stock price moved down to $2.83 following the option alert. Sentiment: BULLISH... 
Via Benzinga
News headline image
The Senseonics Price Will Start to Reflect the Key Advantage of Its Product ↗
With markets in diabetes and wellness, Senseonics’ Eversense is an FDA-approved long-term implantable sensor that spells long-term growth for SENS stock. 
Via InvestorPlace
News headline image
Understanding Senseonics Holdings's Unusual Options Activity ↗
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $3.08. Sentiment:... 
Via Benzinga
News headline image
Innovative Medical Technology Makes Senseonics a Long-Term Buy ↗
Consider a niche-market investment in SENS stock as Senseonics' revenues outside the U.S. should impress even the toughest critics. 
Via InvestorPlace
News headline image
Wait For a Pullback Before Taking a Position In Senseonics ↗
SENS stock has massive potential to establish itself as a major player in the growing CGM market, but is a bit too pricey at this point. 
Via InvestorPlace
News headline image
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Biggest Supporters Have Got to Be Patient ↗
SENS stock has come a long way since the beginning of June. Can it stay on a roll? 
Via InvestorPlace
News headline image
Ignore Near-Sighted Apes and Own Senseonics ↗
Most Reddit profiteering is short-term, but SENS stock has the kind of technology to make it the next big thing for other larger populations. 
Via InvestorPlace
News headline image
3 Pros and 3 Cons to Consider Before Joining the Senseonics Frenzy ↗
Don’t jump into SENS stock before looking at the business from different angles. 
Via InvestorPlace
News headline image
22 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to... 
Via Benzinga
News headline image
Senseonics Has Big Growth Potential From Groundbreaking Diabetes Treatment ↗
Senseonics’ Eversense is the first long-term CGM. This advanced blood glucose monitoring tech will power SENS stock growth. 
Via InvestorPlace
News headline image
Senseonics Announces Presentation of PROMISE Data at the American Diabetes Association 81st Scientific Sessions
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim... 
Via Benzinga
News headline image
Cramer Shares His Thoughts On Sesen Bio, Marathon Oil, More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer with a long position in Senseonics Holdings Inc (NYSE: SENS) to take some off the table. Cramer... 
Via Benzinga
News headline image
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
Senseonics Has Too Much Hope for Success Priced in Already ↗
Reddit investors might be weakening, and Senseonics has to contend with a tough competitor, making SENS stock unattractive. 
Via InvestorPlace
News headline image
Petco Joins Top WallStreetBets Interest Alongside Clean Energy Fuels, Corsair Gaming, AMC As Stock Surges ↗
Petco Health and Wellness Company Inc. (NASDAQ:WOOF) has j... 
Via Benzinga
News headline image
Petco Options Traders Bet An Epic Short Squeeze Is In The Cards ↗
Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) spiked higher on Monday afternoon. Earlier in the day, the company announced plans to present at the Evercore ISI... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.